BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 2492327)

  • 1. V gene rearrangement is required to fully activate the hypermutation mechanism in B cells.
    Roes J; Hüppi K; Rajewsky K; Sablitzky F
    J Immunol; 1989 Feb; 142(3):1022-6. PubMed ID: 2492327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice.
    O'Brien RL; Brinster RL; Storb U
    Nature; 1987 Mar 26-Apr 1; 326(6111):405-9. PubMed ID: 3104790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in Ig V(D)J genes are distributed asymmetrically and independently of the position of V(D)J.
    Weber JS; Berry J; Manser T; Claflin JL
    J Immunol; 1994 Oct; 153(8):3594-602. PubMed ID: 7930582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.
    Schlissel MS; Morrow T
    J Immunol; 1994 Aug; 153(4):1645-57. PubMed ID: 8046237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human.
    Küppers R; Hajadi M; Plank L; Rajewsky K; Hansmann ML
    Eur J Immunol; 1996 Aug; 26(8):1794-800. PubMed ID: 8765023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family.
    Hardy RR; Carmack CE; Shinton SA; Riblet RJ; Hayakawa K
    J Immunol; 1989 May; 142(10):3643-51. PubMed ID: 2497178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion.
    Kitamura D; Rajewsky K
    Nature; 1992 Mar; 356(6365):154-6. PubMed ID: 1545868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position of the rearranged V kappa and its 5' flanking sequences determines the location of somatic mutations in the J kappa locus.
    Weber JS; Berry J; Manser T; Claflin JL
    J Immunol; 1991 May; 146(10):3652-5. PubMed ID: 1902859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation.
    Ikematsu W; Kobarg J; Ikematsu H; Ichiyoshi Y; Casali P
    J Immunol; 1998 Sep; 161(6):2895-905. PubMed ID: 9743351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited junctional diversity in kappa light chains. Junctional sequences from CD43+B220+ early B cell progenitors resemble those from peripheral B cells.
    Victor KD; Vu K; Feeney AJ
    J Immunol; 1994 Apr; 152(7):3467-75. PubMed ID: 7511648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic hypermutation of the JC intron is markedly reduced in unrearranged kappa and H alleles and is unevenly distributed in rearranged alleles.
    Weber JS; Berry J; Litwin S; Claflin JL
    J Immunol; 1991 May; 146(9):3218-26. PubMed ID: 1901897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5' boundary of somatic hypermutation in a V kappa gene is in the leader intron.
    Rada C; González-Fernández A; Jarvis JM; Milstein C
    Eur J Immunol; 1994 Jun; 24(6):1453-7. PubMed ID: 8206104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lineage-restricted rearrangement of a human Ig kappa transgene.
    Cavelier P; Nato F; Coquilleau I; Rolink A; Rougeon F; Goodhardt M
    Eur J Immunol; 1997 Jul; 27(7):1626-31. PubMed ID: 9247570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VH mutant rabbits lacking the VH1a2 gene develop a2+ B cells in the appendix by gene conversion-like alteration of a rearranged VH4 gene.
    Sehgal D; Mage RG; Schiaffella E
    J Immunol; 1998 Feb; 160(3):1246-55. PubMed ID: 9570541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease.
    Cogné M; Bakhshi A; Korsmeyer SJ; Guglielmi P
    J Immunol; 1988 Sep; 141(5):1738-44. PubMed ID: 3137264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin variable region gene analysis to the autoantibody-secreting B cells from tumors in association with paraneoplastic autoimmune multiorgan syndrome.
    Wang J; Bu D; Zhu X
    Int J Dermatol; 2007 Nov; 46(11):1146-54. PubMed ID: 17988333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and kinetic analysis of an epitope-specific shift in the B cell memory response to a multideterminant antigen.
    Press JL; Giorgetti CA
    J Immunol; 1993 Aug; 151(4):1998-2013. PubMed ID: 7688392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
    Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
    Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable kappa gene rearrangement in lymphoproliferative disorders: an analysis of V kappa gene usage, VJ joining and somatic mutation.
    Cannell PK; Amlot P; Attard M; Hoffbrand AV; Foroni L
    Leukemia; 1994 Jul; 8(7):1139-45. PubMed ID: 8035605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.